Tìm theo
Mazindol
Các tên gọi khác (4 ) :
  • Mazindol
  • Mazindolo
  • Mazindolum
  • Sanorex
adrenergic uptake inhibitors, central nervous system stimulants, dopamine uptake inhibitors
Thuốc Gốc
Small Molecule
CAS: 22232-71-9
ATC: A08AA05
CTHH: C16H13ClN2O
PTK: 284.74
Mazindol is a tricyclic anorexigenic agent unrelated to and less toxic than amphetamine, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. Mazindol is only approved in the United States for the treatment of Duchenne muscular dystrophy, and is not marketed or available in the United States for use in the treatment of obesity.
Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Công thức hóa học
Phân tử khối
284.74
Monoisotopic mass
284.071640755
InChI
InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2
InChI Key
InChIKey=ZPXSCAKFGYXMGA-UHFFFAOYSA-N
IUPAC Name
5-(4-chlorophenyl)-2H,3H,5H-imidazo[2,1-a]isoindol-5-ol
Traditional IUPAC Name
mazindol
SMILES
OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
Độ tan chảy
198-199
Độ hòa tan
1.39e-01 g/l
logP
3.7
logS
-3.3
pKa (strongest acidic)
11.61
pKa (Strongest Basic)
3.86
PSA
35.83 Å2
Refractivity
79.42 m3·mol-1
Polarizability
29.42 Å3
Rotatable Bond Count
1
H Bond Acceptor Count
3
H Bond Donor Count
1
Physiological Charge
0
Number of Rings
4
Bioavailability
1
Rule of Five
true
Ghose Filter
true
Dược Lực Học : Mazindol is a sympathomimetic amine, which is similar to an amphetamine. Mazindol stimulates the central nervous system (nerves and brain), which increases your heart rate and blood pressure and decreases your appetite. Sympathomimetic appetite suppressants are used in the short-term treatment of obesity. Their appetite-reducing effect tends to decrease after a few weeks. Because of this, these medicines are useful only during the first few weeks of a weight-loss program.
Cơ Chế Tác Dụng : Mazindol is a tricyclic anorexigenic agent unrelated to and less toxic than amphetamine, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. Mazindol is only approved in the United States for the treatment of Duchenne muscular dystrophy, and is not marketed or available in the United States for use in the treatment of obesity. Although the mechanism of action of the sympathomimetics in the treatment of obesity is not fully known, these medications have pharmacological effects similar to those of amphetamines. Unlike other sympathomimetic appetite suppressants such as phentermine, mazindol is thought to inhibit the reuptake of norepinephrine rather than to cause its release.
Dược Động Học :

▧ Metabolism :
Hepatic.
▧ Half Life :
10-13 hours
Độc Tính : Symptoms of a mazindol overdose include restlessness, tremor, rapid breathing, confusion, hallucinations, panic, aggressiveness, nausea, vomiting, diarrhea, an irregular heartbeat, and seizures.
Chỉ Định : Used in short-term (a few weeks) treatment of exogenous obesity in conjunction with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m2) or in patients with a body mass index of 27 kg/m2 in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.
Tương Tác Thuốc :
  • Acetophenazine Decreased anorexic effect, may increase psychotic symptoms
  • Alimemazine Decreased anorexic effect, may increase psychotic symptoms
  • Chlorpromazine Decreased anorexic effect, may increase psychotic symptoms
  • Ethopropazine Decreased anorexic effect, may increase psychotic symptoms
  • Fluoxetine Risk of serotoninergic syndrome
  • Fluphenazine Decreased anorexic effect, may increase psychotic symptoms
  • Fluvoxamine Risk of serotoninergic syndrome
  • Guanethidine Mazindol may decrease the effect of guanethidine.
  • Isocarboxazid Possible hypertensive crisis
  • Mesoridazine Decreased anorexic effect, may increase psychotic symptoms
  • Methdilazine Decreased anorexic effect, may increase psychotic symptoms
  • Methotrimeprazine Decreased anorexic effect, may increase psychotic symptoms
  • Paroxetine Risk of serotoninergic syndrome
  • Perphenazine Decreased anorexic effect, may increase psychotic symptoms
  • Phenelzine Possible hypertensive crisis
  • Prochlorperazine Decreased anorexic effect, may increase psychotic symptoms.
  • Promazine Decreased anorexic effect, may increase psychotic symptoms
  • Promethazine Decreased anorexic effect, may increase psychotic symptoms.
  • Propericiazine Decreased anorexic effect, may increase psychotic symptoms.
  • Propiomazine Decreased anorexic effect, may increase psychotic symptoms
  • Rasagiline Possible hypertensive crisis
  • Thiethylperazine Decreased anorexic effect, may increase psychotic symptoms
  • Thioridazine Decreased anorexic effect, may increase psychotic symptoms
  • Tranylcypromine Possible hypertensive crisis
  • Trifluoperazine Decreased anorexic effect, may increase psychotic symptoms
  • Triflupromazine Decreased anorexic effect, may increase psychotic symptoms
  • Venlafaxine Risk of serotoninergic syndrome
Dữ Kiện Thương Mại
Nhà Sản Xuất
  • Công ty : Gador
    Sản phẩm biệt dược : Dimagrir
  • Công ty : Cetus
    Sản phẩm biệt dược : Fagolip Plus
  • Công ty : Kwang Dong
    Sản phẩm biệt dược : Mazanor
  • Công ty : Novartis
    Sản phẩm biệt dược : Sanorex
  • Công ty : Novartis
    Sản phẩm biệt dược : Teronac
... loading
... loading